Shots: Abbott received CE Mark for its new quantitative SARS-CoV-2 IgG lab-based serology test. The test measures levels of IgG Abs to help in the evaluation of a person’s immune response The study to determines the clinical performance of Abbott’s SARS-CoV-2 IgG II Quant test on its Alinity i instrument showed that it had 99.60% […]Read More
Shots: The companies collaborated to evaluate the usability of DNA Link’s AccuFind COVID-19 IgG antibody test in a healthcare setting The study intends to expand access to antibody testing outside of laboratory settings The companies plan to launch the study in Dec’2020 Click here to read full press release/ article | Ref: PRNewswire | Image: Base 10 geneticsRead More
Copyright ©2021 PharmaShots | Powered by Octavus Consulting
